WOWp Zomedica Corp

Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference

Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference

ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion animals, announced today that Robert Cohen, Interim Chief Executive Officer, and Stephanie Morley, President and Chief Medical Officer, will present at the upcoming H.C. Wainwright Virtual Global Investment Conference. The presentation is scheduled for September 14, 2020 at 4:00 pm ET.

The slides to be presented by Mr. Cohen and Dr. Morley will be accessible through the Investors section of the Company's website at the morning of the presentation.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to provide veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit .

Follow Zomedica

  • Email Alerts:
  • LinkedIn:
  • Facebook:
  • Twitter:

Investor Relations Contact:

PCG Advisory Group

Kirin Smith, COO



+1 646.863.6519

Media Contact:

Meredith Newman



+1 734.369.2555 ext. 119

EN
10/09/2020

Underlying

WOWpZomedica Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Zomedica Corp

 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Appoints Larry Heaton as President and Announces CEO Successi...

Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan ANN ARBOR, Mich., Oct. 04, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that Larry Heaton has been appointed President effective October 1, 2021. Mr. Heaton will assume the role of Chief Executive Officer upon the retirement of current Chief Executive Officer Robert Cohen on October 31, 2021. Following his retirement, Mr. Cohen will remain on the Board of ...

October 4, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Acquires PulseVet

Zomedica Acquires PulseVet ANN ARBOR, Mich., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse Veterinary Technologies businesses for $70.9 million in an all-cash, stock transaction. Pulse Veterinary Technologies (“PulseVet”) is a world leader in electro-hydraulic shock wave technology for the treatment of a wide variety of conditions in veterinary patients. The high-energy sound w...

October 1, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Sean Whelan Appointed to Board of Directors

Sean Whelan Appointed to Board of Directors ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacancy created by the resignation of Christopher Wolfenberg. Robert Cohen, Zomedica’s Chief Executive Officer, commented that: “We all are very pleased to be joined by an executive with Sean’s sterling background. His broad and deep experience and expert...

September 13, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces Second Quarter 2021 Financial Results

Zomedica Announces Second Quarter 2021 Financial Results TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and six months ended June 30, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of Americ...

August 11, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces 2021 Annual Meeting Results

Zomedica Announces 2021 Annual Meeting Results ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for companion animals, today announced the voting results of its 2021 Annual Virtual-Only Meeting of Shareholders (the “Meeting”) held on July 30, 2021. At the Meeting, the Company’s shareholders approved the items of business as follows: Election of Jeffrey Rowe, Robert Cohen, Johnny D. Powers, Rodney Williams, Chris MacLeod and Christopher Wolfenberg as directors; ...

July 30, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch